Companyhealth ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  21.4% 8.9% 6.3% 6.7% 5.8%  
Credit score (0-100)  5 27 36 35 39  
Credit rating  B BB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  62.1 198 318 1,168 1,329  
EBITDA  42.1 53.7 35.9 67.8 72.8  
EBIT  42.1 53.7 35.9 67.8 72.8  
Pre-tax profit (PTP)  42.1 53.7 34.6 65.5 70.6  
Net earnings  32.8 41.6 26.9 50.3 54.7  
Pre-tax profit without non-rec. items  42.1 53.7 34.6 65.5 70.6  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  32.8 74.5 101 152 206  
Interest-bearing liabilities  0.0 7.3 0.0 0.0 0.0  
Balance sheet total (assets)  136 249 468 796 483  

Net Debt  -5.4 -201 -279 -315 -74.7  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  62.1 198 318 1,168 1,329  
Gross profit growth  0.0% 219.0% 60.5% 267.2% 13.8%  
Employees  0 0 0 0 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  136 249 468 796 483  
Balance sheet change%  0.0% 82.5% 88.4% 69.9% -39.3%  
Added value  42.1 53.7 35.9 67.8 72.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  67.8% 27.1% 11.3% 5.8% 5.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  30.9% 27.9% 10.0% 10.7% 11.4%  
ROI %  128.2% 93.8% 39.2% 53.6% 40.7%  
ROE %  100.0% 77.6% 30.6% 39.7% 30.6%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  24.1% 30.0% 21.6% 19.1% 42.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -12.8% -373.3% -776.9% -464.5% -102.5%  
Gearing %  0.0% 9.8% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 34.8% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.3 1.3 1.1 1.2 1.6  
Current Ratio  1.3 1.3 1.1 1.2 1.6  
Cash and cash equivalent  5.4 207.9 278.9 314.8 74.7  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  32.8 49.2 49.3 99.5 154.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 36  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 36  
EBIT / employee  0 0 0 0 36  
Net earnings / employee  0 0 0 0 27